This double-blinded clinical trial (IRCT2015100313678N7) enrolled 50 RRMS patients (age 20-40 years), who were divided into two groups: the vitamin group, which received three doses of 1 mg vitamin B12 injection (spaced a month apart) plus 5 mg folic acid tablets daily
By inhibiting NNMT, 5-Amino-1MQ increases cellular SAM and NAD+ levels, enhances NAD+ salvage pathway flux, activates SIRT-1, boosts oxidative phosphorylation (OXPHOS), and influences cellular energy homeostasis and epigenetic modifications
Studies have shown that by middle age, NAD+ levels may have decreased by about 50% compared to when one was younger
Why semaglutide depletes vitamin B12 in the first place Understanding the semaglutide methylcobalamin combination requires understanding the problem it attempts to solve
The patient was first seen in our clinic in January 2012